NCT07394712 Comprehensive Maintenance Program: a Health Haven for COPD in Lleida.The NAPOLEON Project.
| NCT ID | NCT07394712 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut de Recerca Biomèdica de Lleida |
| Condition | COPD - Chronic Obstructive Pulmonary Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 86 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 86 participants in total. It began in 2025-10-01 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Introduction: Pulmonary rehabilitation programs (PRPs) are known to reduce symptoms such as dyspnea and fatigue, while improving functional capacity and quality of life in individuals with chronic obstructive pulmonary disease (COPD). However, the benefits of an initial pulmonary rehabilitation program (PRP) tend to diminish rapidly over time, prompting the development of strategies to maintain these effects. Such strategies include supervised exercise programs, telephone follow-ups, and home-based exercise regimens. Nevertheless, the optimal maintenance strategy remains uncertain. Objectives: The primary objective is to evaluate the impact of a supervised, multidimensional maintenance PRP on symptoms and quality of life in individuals with COPD. Additionally, the study aims to compare exercise capacity, healthcare resource utilization, economic benefits, and participant perceptions between the intervention and control groups. Methodology: A 12-month randomized controlled trial (RCT) with two parallel groups will be conducted in adults with COPD who have completed an initial 8-week PRP. Participants will be randomly assigned in a 1:1 ratio to either the intervention or control group. The intervention group will undergo a maintenance PRP consisting of two weekly supervised exercise sessions and monthly educational sessions on COPD in a comprehensive health center over a 3-month period. The control group will receive standard clinical care recommendations regarding physical activity. Clinical evaluations will be conducted at four time points throughout the study: baseline (T0), 3 months (T1), 6 months (T2), and 12 months (T3). Full pulmonary function tests and anthropometric assessments will be performed at T0 and T3. Other variables, including symptom burden, quality of life, functional capacity, mental health, physical activity, sleep-wake pattern, and healthcare utilization, will be systematically collected at all four time points.
Eligibility Criteria
Inclusion Criteria: * Adults aged 40 to 75 years. * Confirmed medical diagnosis of chronic obstructive pulmonary disease (COPD) of moderate to severe severity, based on clinical evaluation and pulmonary function testing. * Clinically stable for at least 4 weeks following the last severe exacerbation, as confirmed by the treating pulmonologist. * Referred to an outpatient pulmonary rehabilitation program due to persistent symptoms and a history of exacerbations, with moderate to severe dyspnea (Medical Research Council \[MRC\] dyspnea scale score \> 2), according to physician assessment. * Completed at least 6 out of 8 sessions of a standard 8-week initial pulmonary rehabilitation program. Exclusion Criteria: * Presence of medical contraindications to physical exercise, including unstable cardiovascular conditions (e.g., recent myocardial infarction, uncontrolled arrhythmias), severe musculoskeletal or neurological disorders, recent surgery, or acute medical conditions (e.g., recent stroke) that impair participation. * Severe cognitive impairment that limits the ability to understand instructions or participate actively in the program. * Unstable psychiatric disorders that may compromise adherence to or continuity with the exercise regimen. * Lack of availability or refusal to attend the scheduled sessions of the community-based exercise program. * Participation in another pulmonary rehabilitation program within the 6 months prior to study enrollment.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07394712 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 75 Years, studying COPD - Chronic Obstructive Pulmonary Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07394712 currently recruiting?
Yes, NCT07394712 is actively recruiting participants. Contact the research team at jgonzalezgutierrez88@gmail.com for enrollment information.
Where is the NCT07394712 trial being conducted?
This trial is being conducted at Lleida, Spain, Lleida, Spain.
Who is sponsoring the NCT07394712 clinical trial?
NCT07394712 is sponsored by Institut de Recerca Biomèdica de Lleida. The trial plans to enroll 86 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.